7 hours ago
1
Rasi Bhadramani/iStock via Getty Images
Sarepta Therapeutics (NASDAQ:SRPT) saw its stock rise in after-hours trading following the announcement of a strategic review that will lead to a workforce reduction of approximately 500 employees, equating to a 36% decrease in staff.The company is now refocusing its pipeline
English (US) ·